Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-α as second-line treatment of advanced transitional cell cancer of the urothelial tract
P. H.M. De Mulder, C. Theodore, A. Sella, O. Koriakine, C. N. Sternberg, L. Collette, C. De Balincourt
Research output: Contribution to journal › Article › peer-review
22Scopus
citations
Fingerprint
Dive into the research topics of 'Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-α as second-line treatment of advanced transitional cell cancer of the urothelial tract'. Together they form a unique fingerprint.